Stockscreener 앱 받기
1.35
15.62%
-0.25
시간 외 거래:
1.36
0.01
+0.74%
Shuttle Pharmaceuticals Holdings Inc 주식(SHPH)의 최신 뉴스
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News - MSN
Shuttle Pharma Raises $4.5M for Clinical Trials - TipRanks
3 Penny Stocks to Watch Now, 10/31/24 - TipRanks
Shuttle Pharmaceuticals Successfully Doses First Patients in Phase 2 Clinical Trial for Glioblastoma Treatment - Defense World
Shuttle Pharma doses three subjects in Phase II glioblastoma treatment trial - Yahoo! Voices
"Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs" - Marketscreener.com
SHPHShuttle Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of - GlobeNewswire
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Benzinga
Shuttle Pharma Pays Off Senior Secured Convertible Note - GlobeNewswire
Micro Cap Company Is Soaring On Phase 2 Trial Update - MSN
Micro Cap Soaring On Phase 2 Trial Update - Invezz
TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail
US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga
Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial - TipRanks
Shuttle Pharma (SHPH) Stock Rises Pre-Market With Completion Site Enrollments - Stocks Telegraph
Shuttle Pharma Doses First Patients in Phase 2 Clinical - GlobeNewswire
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma - Yahoo Finance
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharmaceuticals Shares Rise 63% on Drug-Study Site Update - MarketWatch
Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials - TipRanks
Shuttle Pharma Completes Clinical Trial Site Enrollment for - GlobeNewswire
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - Marketscreener.com
Shuttle Pharmaceuticals to Present at ThinkEquity Conference - TipRanks
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024 - GlobeNewswire
Shuttle Pharmaceuticals completes funding round, raises $790,000 By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals completes funding round, raises $790,000 - Investing.com India
Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $1.3 million in funding - Marketscreener.com
Kingsoft Cloud Holdings Limited (NASDAQ:KC) Short Interest Update - Defense World
Office Properties Income Trust (NASDAQ:OPINL) Shares Up 3.9% – Here’s Why - Defense World
Munters Group AB (publ) (OTCMKTS:MMNNF) Stock Price Down 14.1% – Should You Sell? - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Shares Up 7.2% – Should You Buy? - Defense World
Getlink: Shuttle Traffic in September 2024 - Yahoo Finance
SHPH stock touches 52-week low at $1.11 amid market challenges - Investing.com Australia
SHPH stock touches 52-week low at $1.11 amid market challenges By Investing.com - Investing.com South Africa
Stock Market Today: S&P 500 rides Nvidia-led tech surge to close higher - Investing.com
Union Pacific says FXE issuing some US-Mexico grain shuttle permits - Yahoo Finance
American Century Companies Inc. Lowers Stock Holdings in Paycom Software, Inc. (NYSE:PAYC) - Defense World
Ensign Peak Advisors Inc Sells 13,160 Shares of Owens Corning (NYSE:OC) - Defense World
Frank Rimerman Advisors LLC Takes $386,000 Position in Texas Roadhouse, Inc. (NASDAQ:TXRH) - Defense World
Skandinaviska Enskilda Banken AB publ Sells 2,013 Shares of Funko, Inc. (NASDAQ:FNKO) - Defense World
Thrivent Financial for Lutherans Purchases 32,464 Shares of Global X U.S. Infrastructure Development ETF (BATS:PAVE) - Defense World
Edison International (NYSE:EIX) PT Raised to $72.00 - Defense World
TransDigm Group Incorporated (NYSE:TDG) Stock Holdings Boosted by Zurich Insurance Group Ltd FI - Defense World
Shuttle Pharma advances glioblastoma treatment trial - Investing.com India
Shuttle Pharma advances glioblastoma treatment trial By Investing.com - Investing.com Canada
Shuttle Pharma Expands Clinical Trial Site Enrollment for - GlobeNewswire
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - StockTitan
Shuttle Pharma faces Nasdaq delisting over equity shortfall - Investing.com
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - AccessWire
Deeper Dive: Understanding Shuttle Pharmaceuticals Holdings Inc (SHPH) Through its Various Ratios - The Dwinnex
Shuttle Pharma secures patent for cancer treatment drugs - Investing.com
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Quotes, Forecast and News Summary - Benzinga
Shuttle Pharmaceuticals Holdings Inc [SHPH] fell -34.89% so far this year. What now? - The DBT News
0.88%
0.42%
자본화:
|
볼륨(24시간):